Cargando…

The value of MRI in management of endometrial hyperplasia with atypia

BACKGROUND: The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Natarajan, Purushothaman, Vinturache, Angela, Hutson, Richard, Nugent, David, Broadhead, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011375/
https://www.ncbi.nlm.nih.gov/pubmed/32041614
http://dx.doi.org/10.1186/s12957-020-1811-5
_version_ 1783496056817844224
author Natarajan, Purushothaman
Vinturache, Angela
Hutson, Richard
Nugent, David
Broadhead, Timothy
author_facet Natarajan, Purushothaman
Vinturache, Angela
Hutson, Richard
Nugent, David
Broadhead, Timothy
author_sort Natarajan, Purushothaman
collection PubMed
description BACKGROUND: The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients diagnosed on endometrial biopsy with complex endometrial hyperplasia with atypia (CEHA). METHODS: A retrospective study of 86 cases diagnosed with endometrial hyperplasia with atypia on the initial endometrial biopsy in a tertiary university teaching hospital between 2010 and 2015 was carried out. The MRI accuracy in predicting malignant changes and influence the clinical management was compared among women who had either pelvic MRI, transvaginal ultrasound (TVUS), or no additional imagistic studies. RESULTS: MRI was performed in 24 (28%) and TVUS in 11 (13%)cases, while 51 (59%) women had no additional imagistic studies. In the group of women with no imaging studies, 26/51 (51%) were surgically treated and 8/26 (31%) were diagnosed with endometrial cancer (EEC) stage 1a. In the group of women who had TVUS, 5/11 (45%) were surgically treated and none was diagnosed with EEC. In the group of women who underwent an MRI examination, 20/24 (83%) were surgically treated. Among these, 11/20 (55%) were diagnosed with EEC, 7 had EEC stage 1a, and 4 had EEC stage 1b. Although MRI was able to identify malignant changes with a good sensitivity (91.7%), it had a low specificity in characterisation of malignant transformation (8%). MRI correctly identified 31% of the stage 1a and 33% of the stage 1b endometrial cancer. CONCLUSION: In this study, we found a potential diagnostic value of MRI for identifying malignant transformation in patients with CEHA. However, pelvic MRI has a rather weak predictive value of myometrial invasion in women with CEHA and concurrent EEC. The diagnostic and therapeutic benefits of MRI assessment in patients with CEHA need further validation.
format Online
Article
Text
id pubmed-7011375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70113752020-02-14 The value of MRI in management of endometrial hyperplasia with atypia Natarajan, Purushothaman Vinturache, Angela Hutson, Richard Nugent, David Broadhead, Timothy World J Surg Oncol Research BACKGROUND: The value of the magnetic resonance imaging (MRI) in the assessment of women with endometrial hyperplasia and its role in diagnosis of myometrial invasion or coexistence of cancer is not known. This study aimed to evaluate the accuracy and usefulness of MRI in the management of patients diagnosed on endometrial biopsy with complex endometrial hyperplasia with atypia (CEHA). METHODS: A retrospective study of 86 cases diagnosed with endometrial hyperplasia with atypia on the initial endometrial biopsy in a tertiary university teaching hospital between 2010 and 2015 was carried out. The MRI accuracy in predicting malignant changes and influence the clinical management was compared among women who had either pelvic MRI, transvaginal ultrasound (TVUS), or no additional imagistic studies. RESULTS: MRI was performed in 24 (28%) and TVUS in 11 (13%)cases, while 51 (59%) women had no additional imagistic studies. In the group of women with no imaging studies, 26/51 (51%) were surgically treated and 8/26 (31%) were diagnosed with endometrial cancer (EEC) stage 1a. In the group of women who had TVUS, 5/11 (45%) were surgically treated and none was diagnosed with EEC. In the group of women who underwent an MRI examination, 20/24 (83%) were surgically treated. Among these, 11/20 (55%) were diagnosed with EEC, 7 had EEC stage 1a, and 4 had EEC stage 1b. Although MRI was able to identify malignant changes with a good sensitivity (91.7%), it had a low specificity in characterisation of malignant transformation (8%). MRI correctly identified 31% of the stage 1a and 33% of the stage 1b endometrial cancer. CONCLUSION: In this study, we found a potential diagnostic value of MRI for identifying malignant transformation in patients with CEHA. However, pelvic MRI has a rather weak predictive value of myometrial invasion in women with CEHA and concurrent EEC. The diagnostic and therapeutic benefits of MRI assessment in patients with CEHA need further validation. BioMed Central 2020-02-10 /pmc/articles/PMC7011375/ /pubmed/32041614 http://dx.doi.org/10.1186/s12957-020-1811-5 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Natarajan, Purushothaman
Vinturache, Angela
Hutson, Richard
Nugent, David
Broadhead, Timothy
The value of MRI in management of endometrial hyperplasia with atypia
title The value of MRI in management of endometrial hyperplasia with atypia
title_full The value of MRI in management of endometrial hyperplasia with atypia
title_fullStr The value of MRI in management of endometrial hyperplasia with atypia
title_full_unstemmed The value of MRI in management of endometrial hyperplasia with atypia
title_short The value of MRI in management of endometrial hyperplasia with atypia
title_sort value of mri in management of endometrial hyperplasia with atypia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011375/
https://www.ncbi.nlm.nih.gov/pubmed/32041614
http://dx.doi.org/10.1186/s12957-020-1811-5
work_keys_str_mv AT natarajanpurushothaman thevalueofmriinmanagementofendometrialhyperplasiawithatypia
AT vinturacheangela thevalueofmriinmanagementofendometrialhyperplasiawithatypia
AT hutsonrichard thevalueofmriinmanagementofendometrialhyperplasiawithatypia
AT nugentdavid thevalueofmriinmanagementofendometrialhyperplasiawithatypia
AT broadheadtimothy thevalueofmriinmanagementofendometrialhyperplasiawithatypia
AT natarajanpurushothaman valueofmriinmanagementofendometrialhyperplasiawithatypia
AT vinturacheangela valueofmriinmanagementofendometrialhyperplasiawithatypia
AT hutsonrichard valueofmriinmanagementofendometrialhyperplasiawithatypia
AT nugentdavid valueofmriinmanagementofendometrialhyperplasiawithatypia
AT broadheadtimothy valueofmriinmanagementofendometrialhyperplasiawithatypia